scholarly article | Q13442814 |
P356 | DOI | 10.1182/BLOOD-2006-02-003772 |
P698 | PubMed publication ID | 17420287 |
P2093 | author name string | Annarosa Arcangeli | |
Andrea Becchetti | |||
Serena Pillozzi | |||
Maria Felice Brizzi | |||
Vieri Boddi | |||
Benedetta Bartolozzi | |||
Roberto Caporale | |||
Luigi Pegoraro | |||
Venere Basile | |||
Pietro Antonio Bernabei | |||
P433 | issue | 4 | |
P921 | main subject | cell migration | Q189092 |
acute myeloid leukemia | Q264118 | ||
P304 | page(s) | 1238-1250 | |
P577 | publication date | 2007-04-09 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome | |
P478 | volume | 110 |
Q42395802 | A comment on ion channels as pharmacological targets in oncology |
Q41761513 | A direct interaction between the sigma-1 receptor and the hERG voltage-gated K+ channel revealed by atomic force microscopy and homogeneous time-resolved fluorescence (HTRF®). |
Q36738745 | A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells |
Q48221690 | A role for potassium permeability in the recognition, clearance, and anti-inflammatory effects of apoptotic cells |
Q40019515 | Activation of cell migration with fibroblast growth factor-2 requires calcium-sensitive potassium channels |
Q61813975 | Adhesion Deregulation in Acute Myeloid Leukaemia |
Q36200930 | Aquaporin 2 promotes cell migration and epithelial morphogenesis |
Q37457834 | BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK. |
Q33995612 | Ceramide modulates HERG potassium channel gating by translocation into lipid rafts |
Q37482529 | Characterization of hERG1 channel role in mouse colorectal carcinogenesis. |
Q42660203 | Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups. |
Q43263512 | Effect of Gambogic acid on the regulation of hERG channel in K562 cells in vitro |
Q35600054 | Effect of celastrol on growth inhibition of prostate cancer cells through the regulation of hERG channel in vitro |
Q34927241 | Erg channel is critical in controlling cell volume during cell cycle in embryonic stem cells. |
Q55231478 | Expression of KATP channels in human cervical cancer: Potential tools for diagnosis and therapy. |
Q38184988 | Functional properties of ion channels and transporters in tumour vascularization. |
Q34221680 | HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. |
Q36501076 | HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms |
Q81951836 | ICER expression inhibits leukemia phenotype and controls tumor progression |
Q38707271 | IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines |
Q39971749 | Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells |
Q37173281 | Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells |
Q54334505 | Imatinib has the potential to exert its antileukemia effects by down-regulating hERG1 K+ channels in chronic myelogenous leukemia. |
Q41959589 | Immunohistochemical biomarkers in gastric cancer research and management |
Q64075361 | Implication of Voltage-Gated Potassium Channels in Neoplastic Cell Proliferation |
Q28534789 | Integrated analysis of drug-induced gene expression profiles predicts novel hERG inhibitors |
Q38184985 | Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer |
Q26849490 | Ion channels and transporters in tumour cell migration and invasion |
Q90335558 | Ion channels as therapeutic antibody targets |
Q42277895 | Ion channels in hematopoietic and mesenchymal stem cells |
Q37702927 | Ion channels under the sun. |
Q37152732 | Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer |
Q33699387 | Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway. |
Q27324841 | K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated Manner |
Q39188078 | Kv3.4 potassium channel-mediated electrosignaling controls cell cycle and survival of irradiated leukemia cells |
Q37201859 | LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer |
Q34024653 | Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels. |
Q35862717 | Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group |
Q37783442 | New Insights into the Regulation of Ion Channels by Integrins |
Q38974256 | New Trends in Cancer Therapy: Targeting Ion Channels and Transporters |
Q27007789 | New targets for the antitumor activity of gambogic acid in hematologic malignancies |
Q90193598 | Noncanonical Ion Channel Behaviour in Pain |
Q27015660 | Novel roles for hERG K(+) channels in cell proliferation and apoptosis |
Q37321844 | Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model |
Q42061814 | Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts. |
Q41616259 | Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. |
Q53391411 | Prognostic significance of hERG1 expression in gastric cancer. |
Q43228471 | Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice |
Q39372092 | Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas. |
Q38361335 | Role of ion channels in regulating Ca²⁺ homeostasis during the interplay between immune and cancer cells |
Q38110508 | Roles of ion transport in control of cell motility |
Q35688524 | Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation. |
Q35150041 | Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells. |
Q38896670 | Sigma 1 Receptor and Ion Channel Dynamics in Cancer |
Q90454252 | Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer |
Q37162402 | State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy |
Q36528727 | Stem-cell ecology and stem cells in motion |
Q47827712 | TRPM8 inhibits endothelial cell migration via a non-channel function by trapping the small GTPase Rap1. |
Q33937726 | Targeting potassium channels in cancer |
Q64244710 | The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells |
Q46097844 | The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells. |
Q64913436 | The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma. |
Q33715775 | The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia |
Q46078309 | The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration |
Q36124907 | The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironment |
Q38171243 | The roles of K(+) channels in cancer |
Q38123807 | The sigma-1 receptor: a regulator of cancer cell electrical plasticity? |
Q35661122 | The use of Bcl-2 over-expression to stabilize hybridomas specific to the HERG potassium channel |
Q37521165 | Up-regulation of hERG K⁺ channels by B-RAF. |
Q61454129 | Voltage-gated K channels promote BT-474 breast cancer cell migration |
Q37464784 | Voltage-gated potassium channels as therapeutic targets |
Q35081094 | hERG potassium channel blockage by scorpion toxin BmKKx2 enhances erythroid differentiation of human leukemia cells K562 |
Q35882249 | hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study |
Q35198312 | hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. |
Q39056231 | hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer |
Search more.